Fondaparinux Sodium Injection, Solution
Product Images NDC 11797-155

This text describes a prescription drug called Fondaparinux Sodium Injection, which comes in single-dose prefilled syringes with an automatic needle protection system. The dosage recommended is 2.5 mg per subcutaneous injection, to be taken once a day. The text includes important information about storage conditions and possible allergic reactions as the syringe contains natural latex rubber. The drug is distributed by Zydus Pharmaceuticals, and the text contains product information for pharmacies. Some information is unreadable due to incomplete recognition.*

This is a medication called Fondaparinux Sodium Injection USP, which is a blood thinner used to prevent blood clots. It is administered via subcutaneous injection using a prefilled syringe with a needle protection system. Each syringe contains 2.5mg of fondaparinux sodium in 0.5 mL of solution, and the recommended dose is one daily injection. The medication is stored at room temperature, and precautions should be taken for individuals with a latex allergy. The package includes two single-dose prefilled syringes. The text also provides information on the batch number and expiration date.*

This is a description of Fondaparinux Sodium Injection USP, a medication that comes in a single-dose, prefilled syringe. It contains 5mg of fondaparinux sodium in 0.4ml of an isotonic solution of sodium chloride and water. The recommended dose is a 5mg subcutaneous injection once daily, and it is important to note that the needle guard of the prefilled syringe contains natural latex rubber, which can cause an allergic reaction for latex-sensitive individuals. The medication is manufactured by Italfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA) Inc. It needs to be stored at a temperature between 20°C and 25°C, with excursions permitted between 15°C and 30°C.*

This seems to be a description of Fondaparinux Sodium Injection USP, a medication for subcutaneous use, presented in single-dose prefilled syringes, affixed with an automatic needle protection system. The syringes contain 5mg/0.4mL Fondaparinux Sodium in an isotonic solution of sodium chloride and water for injection, may also contain sodium hydroxide and/or hydrochloric acid as pH adjusters, and the recommended dose is 5mg once daily. The medication should be stored between 20°C to 25°C (68°F to 77°F). The text also includes some identification codes such as NDC 11797-155-09 and GTIN (01) 00370710151591, but it is unclear what they refer to.*

This is a medication described as Fondaparinux Sodium Injection USP, used for subcutaneous injection. Each prefilled syringe contains 7.5 mg of fondaparinux sodium in .06 ml of saline solution. It may also contain other pH adjusters. The needle guard may cause allergies in people sensitive to latex. The recommended dose is 7.5 mg, once a day. The medication is manufactured by Italfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA) Inc. It comes in a package of 10 single-dose prefilled syringes with an automatic needle protection system. The medication is to be stored at a controlled room temperature not exceeding 25°C. *

This text is describing the packaging and use of Fondaparinux Sodium Injection USP, a medicine that comes in single-dose prefilled syringes for subcutaneous use. It also provides the NDC number and information about the recommended dose, storage, and disposal of unused portions. Additionally, it warns about the presence of dry natural latex rubber in the needle guard, which may cause an allergic reaction in latex-sensitive individuals. Batch numbers are also mentioned toward the end of the text.*

This is a description of a 10 mg/0.8 mL Fondaparinux Sodium Injection USP contained in a box of 10 single dose prefilled syringes, which is intended for subcutaneous use only. The product is manufactured by ltalfarmaco S.p.A. and distributed by Zydus Pharmaceuticals (USA), Inc. It is affixed with an automatic needle protection system and accompanied by a pharmacist’s directive. The syringes contain an isotonic solution of sodium chloride and water for injection consisting of 10 mg of fondaparinux sodium, with pH adjusters such as sodium hydroxide and/or hydrochloric acid. The needle guard of the prefilled syringe contains dry natural latex rubber as potential allergens for allergic reactions. The storage of the product should not exceed between 15°C to 30°C (59°F to 86°F). The syringes must be discarded if not used. However, the rest of the description is illegible.*

This is a description of Fondaparinux Sodium Injection USP, a medication intended for subcutaneous use, packaged as prefilled syringes, with each syringe containing 10 mg of fondaparinux sodium in 0.8 mL of an isotonic solution of sodium chloride and water for injection. It is affixed with an automatic needle protection system and contains 2 single doses. The medication may also contain sodium hydroxide and/or hydrochloric acid as pH adjusters. Recommended dosage is 10 mg subcutaneous injection, once daily. The medication should be stored at 20°C to 25°C, and unused portions should be discarded. The text also includes information regarding the packaging, such as the NDC number, GTIN, SN, expiry date, and batch number. Note: There are some errors that are not correctable in the given text.*

This text provides instructions for administering an injection using a syringe. It advises to remove the needle shield, discard the needle guard, avoid touching the needle or letting it touch any surface, not remove air bubbles from the syringe, and gently pinch and hold the skin to make a fold. It also instructs to insert the full length of the needle directly up and down into the skin fold at a 90° angle. Two figures are included to illustrate the steps.*

This text provides instructions on how to properly use a syringe for medicine injection. It explains how to inject the medicine by pressing down on the plunger, how to remove the syringe from the injection site, and how to activate the safety system. The safety system can only be activated once the syringe has been emptied and must be done after removing the needle from the patient’s skin. The safety system should not be sterilized, and the activation of the safety system may cause minimal splatter of fluid.*

This text provides instructions for the proper disposal of used fondaparinux sodium injection needles and syringes. It advises the use of an FDA-cleared sharps disposal container or a household container that meets certain safety requirements. The community guidelines for disposing of sharps disposal containers when they are full should be followed, and disposal of these containers in household trash is prohibited. The text also provides information about the manufacturer and distributor of fondaparinux sodium injection.*